Lux Capital is a venture capital firm established in 2000 and headquartered in New York, New York. The firm specializes in investments in early-stage and growth companies, focusing on sectors such as biochemistry, material science, electronics, infrastructure, and aerospace. With over $5 billion in assets under management, Lux Capital takes an active role in supporting entrepreneurs, aiming to build successful businesses in high-growth industries. The investment team has a track record of founding more than 20 companies, employing strategies that enhance connectivity, insight, and competitive leadership for its portfolio companies. As a Registered Investment Adviser, Lux Capital is committed to fostering innovation at the intersection of technology and the sciences.
Mendaera is a medtech startup that specializes in developing advanced healthcare technologies, with a focus on robotics and diagnostic tools. The company aims to enhance clinical judgment and technical expertise to make high-quality care accessible to all patients across various care facilities. Mendaera's innovative platform, currently in development, combines real-time imaging, robotics, and artificial intelligence to assist physicians in both image acquisition and interpretation. This integration facilitates precise and consistent point-of-care interventions, streamlining the patient journey, accelerating recovery, and reducing overall care costs. By empowering healthcare professionals with these advanced technologies, Mendaera seeks to improve the efficacy and accessibility of medical procedures.
LabGenius
Series B in 2024
LabGenius Ltd is a biopharmaceutical company based in London that focuses on discovering new biological molecules through the integration of artificial intelligence, automation, and synthetic DNA. Founded in 2012, the company has developed a robotic platform known as EVA, which acts as a robot scientist capable of designing, conducting, and learning from its own experiments. LabGenius specializes in developing next-generation protein therapeutics aimed at addressing unmet medical needs, including conditions like Inflammatory Bowel Disease. Their innovative approach utilizes advanced machine learning and synthetic biology to engineer the properties of protein drugs, enhancing attributes such as protease stability and tissue penetration. This technology enables the efficient creation of protein therapeutics, providing physicians with access to cutting-edge treatments developed through robotic automation.
Ripcord
Venture Round in 2024
Ripcord, Inc. is a robotic digitization company founded in 2014 and headquartered in Los Angeles, California. The company specializes in creating a platform for paperless document management, utilizing advanced technologies such as artificial intelligence, machine learning, and vision-guided robotics. Their primary product, Canopy, employs automation software to capture, enrich, and organize essential content, effectively creating a digital twin of information. By integrating sensors and software automation, Ripcord enables enterprises to enhance their business processes, improving speed, quality, and accuracy in managing important documents. The company, originally known as Ripcord Digital, Inc., rebranded in June 2017 to reflect its focus on innovative digitization solutions.
Collaborative Robotics
Series B in 2024
Collaborative Robotics is a team of innovators and builders redefining the future of human-robot interaction. A future in which robots are trustworthy extensions of the environment. They operate, adapt, and react in response.
Formic
Venture Round in 2024
Formic is a robotics company dedicated to enhancing automation in labor-intensive industries such as food and beverage, advanced manufacturing, and consumer packaged goods. The company focuses on making robotic deployments accessible and straightforward, offering manufacturers flexible automation solutions that allow them to pay based on productivity rather than upfront costs. By combining financial innovation with expertise in robotics, Formic enables businesses to scale their manufacturing capabilities quickly and with reduced risk. The company's mission is to democratize access to automation, ensuring that every factory can benefit from the efficiencies provided by advanced robotic systems.
Physical Intelligence
Seed Round in 2024
Physical Intelligence is a company working on integrating general-purpose AI with robotics and physical devices. It develops foundation models and learning algorithms for robots to allow industries to perform tasks across various applications.
Instock
Seed Round in 2023
Instock is a developer of an innovative e-commerce platform that specializes in Robotics-as-a-Service for e-commerce operations. The company's system employs a 3D goods-to-person (G2P) approach, integrating advanced software-defined automation and a simulation-first methodology. This technology is designed to meet market demands by optimizing fulfillment processes, which helps to significantly reduce transit times. As a result, Instock enables its customers to lower shipping costs while ensuring faster delivery of orders. The platform also features embedded self-service capabilities, streamlining day-to-day operations for users.
Kinetic Automation
Series A in 2023
Kinetic Automation is transforming the automotive repair industry by developing an advanced infrastructure that integrates hardware, robotics, software, and artificial intelligence. The company focuses on providing mobility services specifically for electric and autonomous vehicles through its automated repair centers. Utilizing precision technology powered by machine learning, Kinetic aims to deliver rapid, accurate, and predictable maintenance solutions. Its innovative approach positions Kinetic as a key player in the future of automotive servicing, facilitating essential support for electric vehicle owners and enhancing the overall efficiency of vehicle maintenance.
Mendaera
Series A in 2023
Mendaera is a medtech startup that specializes in developing advanced healthcare technologies, with a focus on robotics and diagnostic tools. The company aims to enhance clinical judgment and technical expertise to make high-quality care accessible to all patients across various care facilities. Mendaera's innovative platform, currently in development, combines real-time imaging, robotics, and artificial intelligence to assist physicians in both image acquisition and interpretation. This integration facilitates precise and consistent point-of-care interventions, streamlining the patient journey, accelerating recovery, and reducing overall care costs. By empowering healthcare professionals with these advanced technologies, Mendaera seeks to improve the efficacy and accessibility of medical procedures.
Mythic
Venture Round in 2023
Mythic Inc. is a technology company that designs and develops silicon chips and artificial intelligence processing units (IPUs) for a wide range of applications, from consumer electronics and wearables to autonomous vehicles and robotic drones. Founded in 2012 and headquartered in Redwood City, California, with an additional office in Austin, Texas, Mythic specializes in analog matrix processors that utilize unique compute-in-memory technology. Their products, including the M1076 Analog Matrix Processor and various PCIe and M.2 cards, integrate AI capabilities directly into compact chips, enabling desktop-level processing power in smaller devices. The company emphasizes its expertise in neural networks, processor architecture, and software design to deliver efficient AI solutions while maintaining performance, power efficiency, and accuracy in real-world environments.
Formic
Series A in 2022
Formic is a robotics company dedicated to enhancing automation in labor-intensive industries such as food and beverage, advanced manufacturing, and consumer packaged goods. The company focuses on making robotic deployments accessible and straightforward, offering manufacturers flexible automation solutions that allow them to pay based on productivity rather than upfront costs. By combining financial innovation with expertise in robotics, Formic enables businesses to scale their manufacturing capabilities quickly and with reduced risk. The company's mission is to democratize access to automation, ensuring that every factory can benefit from the efficiencies provided by advanced robotic systems.
Saildrone
Series C in 2021
Saildrone, Inc. specializes in the design and manufacture of wind and solar-powered autonomous surface vehicles, known as Saildrones, which facilitate cost-effective ocean data collection at scale. Founded in 2012 and based in Alameda, California, the company operates a fleet of these drones to gather live ocean data for various applications, including weather forecasting, oceanography, fish stock analysis, and environmental monitoring. Saildrone's vehicles have traveled over 500,000 nautical miles and spent more than 13,000 days at sea, generating high-resolution datasets that provide critical insights for climate science, maritime security, and ecological management. By utilizing real-time data transmission via satellite, Saildrone enables clients to monitor and mitigate potential ecological disasters, contributing to better understanding and management of global environmental challenges.
Formic
Seed Round in 2021
Formic is a robotics company dedicated to enhancing automation in labor-intensive industries such as food and beverage, advanced manufacturing, and consumer packaged goods. The company focuses on making robotic deployments accessible and straightforward, offering manufacturers flexible automation solutions that allow them to pay based on productivity rather than upfront costs. By combining financial innovation with expertise in robotics, Formic enables businesses to scale their manufacturing capabilities quickly and with reduced risk. The company's mission is to democratize access to automation, ensuring that every factory can benefit from the efficiencies provided by advanced robotic systems.
Strateos
Series B in 2021
Strateos is a company that specializes in automating laboratory processes in chemistry, biology, and tissue analysis through its advanced robotic cloud laboratory platform. By integrating cutting-edge robotics with sophisticated software for imaging and analytics, Strateos provides pharmaceutical partners with the tools to accelerate drug discovery and development. The company emerged from a merger between Transcriptic, which pioneered on-demand robotic lab services, and 3Scan, known for its automation and machine learning capabilities in tissue analysis. Strateos aims to streamline the drug discovery process by offering a comprehensive suite of technologies that transform life science methods into data-driven solutions. This approach not only enhances productivity and efficiency but also redefines the traditional research model, making it more accessible and effective for scientists. Through its innovative platform, Strateos positions itself as a valuable partner in the life sciences sector, focusing on delivering significant time and cost savings in the drug development process.
Multiply Labs
Series A in 2021
Multiply Labs specializes in the production of personalized pharmaceutical capsules that cater to the unique needs of individual patients. The company leverages a combination of pharmaceutical science and advanced robotics technology to create these tailor-made capsules. Its innovative approach includes operating a state-of-the-art robotic manufacturing facility, which allows for the efficient production of individualized drugs at a reduced cost. Multiply Labs stands out as a pioneer in the industry, being the first to introduce 3D printed capsules, thereby transforming how medications are customized to meet the specific metabolic requirements of patients.
LabGenius
Series A in 2020
LabGenius Ltd is a biopharmaceutical company based in London that focuses on discovering new biological molecules through the integration of artificial intelligence, automation, and synthetic DNA. Founded in 2012, the company has developed a robotic platform known as EVA, which acts as a robot scientist capable of designing, conducting, and learning from its own experiments. LabGenius specializes in developing next-generation protein therapeutics aimed at addressing unmet medical needs, including conditions like Inflammatory Bowel Disease. Their innovative approach utilizes advanced machine learning and synthetic biology to engineer the properties of protein drugs, enhancing attributes such as protease stability and tissue penetration. This technology enables the efficient creation of protein therapeutics, providing physicians with access to cutting-edge treatments developed through robotic automation.
Ripcord
Series B in 2020
Ripcord, Inc. is a robotic digitization company founded in 2014 and headquartered in Los Angeles, California. The company specializes in creating a platform for paperless document management, utilizing advanced technologies such as artificial intelligence, machine learning, and vision-guided robotics. Their primary product, Canopy, employs automation software to capture, enrich, and organize essential content, effectively creating a digital twin of information. By integrating sensors and software automation, Ripcord enables enterprises to enhance their business processes, improving speed, quality, and accuracy in managing important documents. The company, originally known as Ripcord Digital, Inc., rebranded in June 2017 to reflect its focus on innovative digitization solutions.
Performance Drone Works
Seed Round in 2020
Performance Drone Works specializes in the development of small autonomous unmanned aerial systems (UAS) tailored for modern military applications. The company focuses on creating innovative technology that enhances mission effectiveness while reducing risks to personnel. Its platforms are designed with a common framework in electronics and software, allowing for consistency across various sizes of drones. Notably, the UAS includes advanced features such as a 3D-vision obstacle avoidance system, enabling operations in environments where GPS signals are unavailable. This capability significantly enhances the operational effectiveness of the modern warfighter.
LabGenius
Series A in 2019
LabGenius Ltd is a biopharmaceutical company based in London that focuses on discovering new biological molecules through the integration of artificial intelligence, automation, and synthetic DNA. Founded in 2012, the company has developed a robotic platform known as EVA, which acts as a robot scientist capable of designing, conducting, and learning from its own experiments. LabGenius specializes in developing next-generation protein therapeutics aimed at addressing unmet medical needs, including conditions like Inflammatory Bowel Disease. Their innovative approach utilizes advanced machine learning and synthetic biology to engineer the properties of protein drugs, enhancing attributes such as protease stability and tissue penetration. This technology enables the efficient creation of protein therapeutics, providing physicians with access to cutting-edge treatments developed through robotic automation.
Strateos
Venture Round in 2019
Strateos is a company that specializes in automating laboratory processes in chemistry, biology, and tissue analysis through its advanced robotic cloud laboratory platform. By integrating cutting-edge robotics with sophisticated software for imaging and analytics, Strateos provides pharmaceutical partners with the tools to accelerate drug discovery and development. The company emerged from a merger between Transcriptic, which pioneered on-demand robotic lab services, and 3Scan, known for its automation and machine learning capabilities in tissue analysis. Strateos aims to streamline the drug discovery process by offering a comprehensive suite of technologies that transform life science methods into data-driven solutions. This approach not only enhances productivity and efficiency but also redefines the traditional research model, making it more accessible and effective for scientists. Through its innovative platform, Strateos positions itself as a valuable partner in the life sciences sector, focusing on delivering significant time and cost savings in the drug development process.
Mythic
Series B in 2019
Mythic Inc. is a technology company that designs and develops silicon chips and artificial intelligence processing units (IPUs) for a wide range of applications, from consumer electronics and wearables to autonomous vehicles and robotic drones. Founded in 2012 and headquartered in Redwood City, California, with an additional office in Austin, Texas, Mythic specializes in analog matrix processors that utilize unique compute-in-memory technology. Their products, including the M1076 Analog Matrix Processor and various PCIe and M.2 cards, integrate AI capabilities directly into compact chips, enabling desktop-level processing power in smaller devices. The company emphasizes its expertise in neural networks, processor architecture, and software design to deliver efficient AI solutions while maintaining performance, power efficiency, and accuracy in real-world environments.
Veo Robotics
Series A in 2019
Veo Robotics is transforming manufacturing with products that incorporate advanced computer vision, 3D sensing, and AI. Their first product lets high-performance industrial robots work collaboratively with people to enable much more flexible, productive, and efficient manufacturing workcells.
CTRL-Labs
Venture Round in 2019
CTRL-Labs Corporation, founded in 2015 and based in New York City, specializes in developing non-invasive neural interface technology aimed at enhancing the interaction between humans and machines. The company's flagship product, the CTRL-kit, is a wireless wristband equipped with sensors that captures neural signals, allowing users to control digital devices through simple electronic pulses. This innovative platform is designed to support various applications in virtual reality, augmented reality, robotics, productivity, and clinical research. By providing developers with a software development kit (SDK) and application programming interface (API), CTRL-Labs enables the integration of neural control into their applications. The company's long-term vision focuses on fostering mass consumer adoption of neural interfaces, establishing a new standard for human-machine collaboration that transforms how users engage with technology.
Auris Health
Series E in 2018
Auris Health, Inc., based in Redwood City, California, develops innovative robotic technology for medical applications, particularly in the field of endoscopy. The company is known for its Monarch Platform, which facilitates diagnostic and therapeutic bronchoscopic procedures by utilizing small cameras and tools that access the body through natural openings. In addition to endoscopic applications, Auris Health is creating a novel dual-arm microsurgical system aimed at enhancing ophthalmic surgery. By integrating advancements in imaging technology, robotics, micro-instrumentation, and data science, Auris Health seeks to transform medical interventions, ultimately improving patient outcomes and reducing costs. Founded in 2007, the company operates as a subsidiary of Johnson & Johnson.
Bright Machines
Series A in 2018
Bright Machines, Inc. is a manufacturing company founded in 2018 and based in San Francisco, California, with additional offices in Tel Aviv, China, and Mexico. The company specializes in creating robotic arms and cells for micro factories, focusing on the assembly and inspection of electronic products. It aims to reduce manual labor in manufacturing by integrating advanced robotics with a software-defined manufacturing platform. This platform leverages artificial intelligence, machine learning, and production data to enhance automation processes, resulting in robots that are adaptable and equipped with sensor technology and computer vision. Bright Machines enables its clients to innovate rapidly and achieve better production yields at lower costs, meeting the evolving demands of the manufacturing sector.
Aeva
Series A in 2018
Aeva is a machine vision company that specializes in developing advanced optical-based sensors, particularly in the field of lidar technology, which is essential for autonomous vehicles. Founded in 2016 and headquartered in Mountain View, California, Aeva integrates vision, depth, and motion sensing into a single product that delivers superior performance regarding range, resolution, and velocity measurement under various weather conditions. Its proprietary Frequency Modulated Continuous Wave (FMCW) technology enables the creation of a 4D LiDAR-on-chip, which has applications beyond automated driving, including consumer electronics, health, industrial automation, and security. Aeva operates primarily in North America, EMEA, and Asia, with the majority of its revenue generated from the North American market.
CTRL-Labs
Series B in 2018
CTRL-Labs Corporation, founded in 2015 and based in New York City, specializes in developing non-invasive neural interface technology aimed at enhancing the interaction between humans and machines. The company's flagship product, the CTRL-kit, is a wireless wristband equipped with sensors that captures neural signals, allowing users to control digital devices through simple electronic pulses. This innovative platform is designed to support various applications in virtual reality, augmented reality, robotics, productivity, and clinical research. By providing developers with a software development kit (SDK) and application programming interface (API), CTRL-Labs enables the integration of neural control into their applications. The company's long-term vision focuses on fostering mass consumer adoption of neural interfaces, establishing a new standard for human-machine collaboration that transforms how users engage with technology.
Saildrone
Series B in 2018
Saildrone, Inc. specializes in the design and manufacture of wind and solar-powered autonomous surface vehicles, known as Saildrones, which facilitate cost-effective ocean data collection at scale. Founded in 2012 and based in Alameda, California, the company operates a fleet of these drones to gather live ocean data for various applications, including weather forecasting, oceanography, fish stock analysis, and environmental monitoring. Saildrone's vehicles have traveled over 500,000 nautical miles and spent more than 13,000 days at sea, generating high-resolution datasets that provide critical insights for climate science, maritime security, and ecological management. By utilizing real-time data transmission via satellite, Saildrone enables clients to monitor and mitigate potential ecological disasters, contributing to better understanding and management of global environmental challenges.
Mythic
Series B in 2018
Mythic Inc. is a technology company that designs and develops silicon chips and artificial intelligence processing units (IPUs) for a wide range of applications, from consumer electronics and wearables to autonomous vehicles and robotic drones. Founded in 2012 and headquartered in Redwood City, California, with an additional office in Austin, Texas, Mythic specializes in analog matrix processors that utilize unique compute-in-memory technology. Their products, including the M1076 Analog Matrix Processor and various PCIe and M.2 cards, integrate AI capabilities directly into compact chips, enabling desktop-level processing power in smaller devices. The company emphasizes its expertise in neural networks, processor architecture, and software design to deliver efficient AI solutions while maintaining performance, power efficiency, and accuracy in real-world environments.
Ripcord
Series B in 2017
Ripcord, Inc. is a robotic digitization company founded in 2014 and headquartered in Los Angeles, California. The company specializes in creating a platform for paperless document management, utilizing advanced technologies such as artificial intelligence, machine learning, and vision-guided robotics. Their primary product, Canopy, employs automation software to capture, enrich, and organize essential content, effectively creating a digital twin of information. By integrating sensors and software automation, Ripcord enables enterprises to enhance their business processes, improving speed, quality, and accuracy in managing important documents. The company, originally known as Ripcord Digital, Inc., rebranded in June 2017 to reflect its focus on innovative digitization solutions.
Covariant
Seed Round in 2017
Covariant is a developer of artificial intelligence for robotics. Covariant is building the Covariant Brain, a universal AI to give robots the ability to see, reason and act on the world around them.
Veo Robotics
Series A in 2017
Veo Robotics is transforming manufacturing with products that incorporate advanced computer vision, 3D sensing, and AI. Their first product lets high-performance industrial robots work collaboratively with people to enable much more flexible, productive, and efficient manufacturing workcells.
Ripcord
Series B in 2017
Ripcord, Inc. is a robotic digitization company founded in 2014 and headquartered in Los Angeles, California. The company specializes in creating a platform for paperless document management, utilizing advanced technologies such as artificial intelligence, machine learning, and vision-guided robotics. Their primary product, Canopy, employs automation software to capture, enrich, and organize essential content, effectively creating a digital twin of information. By integrating sensors and software automation, Ripcord enables enterprises to enhance their business processes, improving speed, quality, and accuracy in managing important documents. The company, originally known as Ripcord Digital, Inc., rebranded in June 2017 to reflect its focus on innovative digitization solutions.
Auris Health
Series D in 2017
Auris Health, Inc., based in Redwood City, California, develops innovative robotic technology for medical applications, particularly in the field of endoscopy. The company is known for its Monarch Platform, which facilitates diagnostic and therapeutic bronchoscopic procedures by utilizing small cameras and tools that access the body through natural openings. In addition to endoscopic applications, Auris Health is creating a novel dual-arm microsurgical system aimed at enhancing ophthalmic surgery. By integrating advancements in imaging technology, robotics, micro-instrumentation, and data science, Auris Health seeks to transform medical interventions, ultimately improving patient outcomes and reducing costs. Founded in 2007, the company operates as a subsidiary of Johnson & Johnson.
Mythic
Series A in 2017
Mythic Inc. is a technology company that designs and develops silicon chips and artificial intelligence processing units (IPUs) for a wide range of applications, from consumer electronics and wearables to autonomous vehicles and robotic drones. Founded in 2012 and headquartered in Redwood City, California, with an additional office in Austin, Texas, Mythic specializes in analog matrix processors that utilize unique compute-in-memory technology. Their products, including the M1076 Analog Matrix Processor and various PCIe and M.2 cards, integrate AI capabilities directly into compact chips, enabling desktop-level processing power in smaller devices. The company emphasizes its expertise in neural networks, processor architecture, and software design to deliver efficient AI solutions while maintaining performance, power efficiency, and accuracy in real-world environments.
Ripcord
Series A in 2017
Ripcord, Inc. is a robotic digitization company founded in 2014 and headquartered in Los Angeles, California. The company specializes in creating a platform for paperless document management, utilizing advanced technologies such as artificial intelligence, machine learning, and vision-guided robotics. Their primary product, Canopy, employs automation software to capture, enrich, and organize essential content, effectively creating a digital twin of information. By integrating sensors and software automation, Ripcord enables enterprises to enhance their business processes, improving speed, quality, and accuracy in managing important documents. The company, originally known as Ripcord Digital, Inc., rebranded in June 2017 to reflect its focus on innovative digitization solutions.
Saildrone
Series A in 2017
Saildrone, Inc. specializes in the design and manufacture of wind and solar-powered autonomous surface vehicles, known as Saildrones, which facilitate cost-effective ocean data collection at scale. Founded in 2012 and based in Alameda, California, the company operates a fleet of these drones to gather live ocean data for various applications, including weather forecasting, oceanography, fish stock analysis, and environmental monitoring. Saildrone's vehicles have traveled over 500,000 nautical miles and spent more than 13,000 days at sea, generating high-resolution datasets that provide critical insights for climate science, maritime security, and ecological management. By utilizing real-time data transmission via satellite, Saildrone enables clients to monitor and mitigate potential ecological disasters, contributing to better understanding and management of global environmental challenges.
Zoox
Series A in 2016
Zoox is a California based robotics company founded by Tim Kentley-Klay and Dr. Jesse Levinson to create autonomous mobility. Operating at the intersection of design, computer science, and electro-mechanical engineering, Zoox is a multidisciplinary team working to imagine and build an advanced mobility experience that will support the future needs of urban mobility for both people and the environment.
Saildrone
Series A in 2016
Saildrone, Inc. specializes in the design and manufacture of wind and solar-powered autonomous surface vehicles, known as Saildrones, which facilitate cost-effective ocean data collection at scale. Founded in 2012 and based in Alameda, California, the company operates a fleet of these drones to gather live ocean data for various applications, including weather forecasting, oceanography, fish stock analysis, and environmental monitoring. Saildrone's vehicles have traveled over 500,000 nautical miles and spent more than 13,000 days at sea, generating high-resolution datasets that provide critical insights for climate science, maritime security, and ecological management. By utilizing real-time data transmission via satellite, Saildrone enables clients to monitor and mitigate potential ecological disasters, contributing to better understanding and management of global environmental challenges.
3Scan
Series B in 2016
3Scan is turning tissue into bits by building robotic microscopy tools and software for large-scale sample analysis and 3D visualizations. Many diseases emerge only at a tissue level, such as cancer, heart disease, lung disease, stroke, Alzheimer's, and diabetes. 3Scan enables higher throughput, greater quantification, and broader image analysis than what is currently possible with traditional histopathology. 3Scan's data-driven approach is expanding our understanding of tissue biology and will lead to the discovery of new diagnostics and therapeutics. The company was founded in 2011 and is headquartered in San Francisco, California.
Auris Health
Series B in 2015
Auris Health, Inc., based in Redwood City, California, develops innovative robotic technology for medical applications, particularly in the field of endoscopy. The company is known for its Monarch Platform, which facilitates diagnostic and therapeutic bronchoscopic procedures by utilizing small cameras and tools that access the body through natural openings. In addition to endoscopic applications, Auris Health is creating a novel dual-arm microsurgical system aimed at enhancing ophthalmic surgery. By integrating advancements in imaging technology, robotics, micro-instrumentation, and data science, Auris Health seeks to transform medical interventions, ultimately improving patient outcomes and reducing costs. Founded in 2007, the company operates as a subsidiary of Johnson & Johnson.
Plethora
Venture Round in 2015
Plethora Corporation, founded in 2012 and headquartered in San Francisco, California, specializes in precision machining services, particularly in CNC machining, milling, and turning. The company works with materials such as aluminum alloys, copper alloys, plastics, steels, and stainless steels. Plethora serves a diverse range of industries, including robotics, automotive, aerospace, and consumer packaged goods, primarily within the United States. Utilizing advanced robotics and proprietary software, Plethora transforms customer designs into custom parts and offers design feedback directly from clients' CAD models, enhancing the manufacturing process. Additionally, Plethora maintains an office in Marietta, Georgia, to support its operational capabilities.
Zoox
Seed Round in 2015
Zoox is a California based robotics company founded by Tim Kentley-Klay and Dr. Jesse Levinson to create autonomous mobility. Operating at the intersection of design, computer science, and electro-mechanical engineering, Zoox is a multidisciplinary team working to imagine and build an advanced mobility experience that will support the future needs of urban mobility for both people and the environment.
3Scan
Series A in 2014
3Scan is turning tissue into bits by building robotic microscopy tools and software for large-scale sample analysis and 3D visualizations. Many diseases emerge only at a tissue level, such as cancer, heart disease, lung disease, stroke, Alzheimer's, and diabetes. 3Scan enables higher throughput, greater quantification, and broader image analysis than what is currently possible with traditional histopathology. 3Scan's data-driven approach is expanding our understanding of tissue biology and will lead to the discovery of new diagnostics and therapeutics. The company was founded in 2011 and is headquartered in San Francisco, California.
Strateos
Seed Round in 2014
Strateos is a company that specializes in automating laboratory processes in chemistry, biology, and tissue analysis through its advanced robotic cloud laboratory platform. By integrating cutting-edge robotics with sophisticated software for imaging and analytics, Strateos provides pharmaceutical partners with the tools to accelerate drug discovery and development. The company emerged from a merger between Transcriptic, which pioneered on-demand robotic lab services, and 3Scan, known for its automation and machine learning capabilities in tissue analysis. Strateos aims to streamline the drug discovery process by offering a comprehensive suite of technologies that transform life science methods into data-driven solutions. This approach not only enhances productivity and efficiency but also redefines the traditional research model, making it more accessible and effective for scientists. Through its innovative platform, Strateos positions itself as a valuable partner in the life sciences sector, focusing on delivering significant time and cost savings in the drug development process.
Plethora
Series A in 2014
Plethora Corporation, founded in 2012 and headquartered in San Francisco, California, specializes in precision machining services, particularly in CNC machining, milling, and turning. The company works with materials such as aluminum alloys, copper alloys, plastics, steels, and stainless steels. Plethora serves a diverse range of industries, including robotics, automotive, aerospace, and consumer packaged goods, primarily within the United States. Utilizing advanced robotics and proprietary software, Plethora transforms customer designs into custom parts and offers design feedback directly from clients' CAD models, enhancing the manufacturing process. Additionally, Plethora maintains an office in Marietta, Georgia, to support its operational capabilities.
Auris Health
Series A in 2014
Auris Health, Inc., based in Redwood City, California, develops innovative robotic technology for medical applications, particularly in the field of endoscopy. The company is known for its Monarch Platform, which facilitates diagnostic and therapeutic bronchoscopic procedures by utilizing small cameras and tools that access the body through natural openings. In addition to endoscopic applications, Auris Health is creating a novel dual-arm microsurgical system aimed at enhancing ophthalmic surgery. By integrating advancements in imaging technology, robotics, micro-instrumentation, and data science, Auris Health seeks to transform medical interventions, ultimately improving patient outcomes and reducing costs. Founded in 2007, the company operates as a subsidiary of Johnson & Johnson.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.